Targeted radiation slows prostate cancer spread in early trial
NCT ID NCT04443062
First seen Feb 28, 2026 · Last updated May 12, 2026 · Updated 14 times
Summary
This study tested a new radiation treatment (177Lu-PSMA) in 58 men with prostate cancer that had spread to a few spots but was still hormone-sensitive. The treatment targets cancer cells specifically, aiming to delay disease progression compared to standard care. Results help determine if this approach can control the cancer longer without needing stronger hormone therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam UMC
Amsterdam, Netherlands
-
German Oncology Center
Limassol, Cyprus
-
Radboud University
Nijmegen, Netherlands
-
University Medical Center Groningen
Groningen, Netherlands
Conditions
Explore the condition pages connected to this study.